Cytochrome p450 2C (CYP2C) in ischemic heart injury and vascular dysfunction (Q36538334)

14 August 2017

1 reference

title

Cytochrome p450 2C (CYP2C) in ischemic heart injury and vascular dysfunction (English)

1 reference

14 August 2017

1 reference

Manreet K Chehal

1

1 reference

14 August 2017

David J Granville

series ordinal

2

1 reference

14 August 2017

publication date

1 January 2006

1 reference

Canadian Journal of Physiology and Pharmacology

14 August 2017

published in

1 reference

14 August 2017

volume

84

1 reference

14 August 2017

issue

1

1 reference

14 August 2017

page(s)

15-20

1 reference

Evidence of cardiovascular protection by moderate alcohol: role of nitric oxide

14 August 2017

cites work

1 reference

Regulation of endothelium-derived vasoactive autacoid production by hemodynamic forces.

21 January 2018

1 reference

EDHF: bringing the concepts together

21 January 2018

1 reference

Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors

21 January 2018

1 reference

Epoxyeicosatrienoic acids and their sulfonimide derivatives stimulate tyrosine phosphorylation and induce mitogenesis in renal epithelial cells

21 January 2018

1 reference

Cytochrome p450 epoxygenase metabolism of arachidonic acid inhibits apoptosis

21 January 2018

1 reference

Inhibitors of cytochrome P450 4A suppress angiogenic responses

21 January 2018

1 reference

Polymorphisms in human CYP2C8 decrease metabolism of the anticancer drug paclitaxel and arachidonic acid.

21 January 2018

1 reference

Microsomal monooxygenase in apoptosis: another target for cytochrome c signaling?

21 January 2018

1 reference

Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines

21 January 2018

1 reference

Cytochrome p-450 epoxygenase products contribute to attenuated vasoconstriction after chronic hypoxia

21 January 2018

1 reference

Inhibition of cytochrome P450 2C9 improves endothelium-dependent, nitric oxide-mediated vasodilatation in patients with coronary artery disease

21 January 2018

1 reference

Cytochrome P450 2C is an EDHF synthase in coronary arteries

21 January 2018

1 reference

Cytochrome P450 epoxygenases and vascular tone: novel role for HMG-CoA reductase inhibitors in the regulation of CYP 2C expression

21 January 2018

1 reference

Cytochrome p450 and vascular homeostasis

21 January 2018

1 reference

Cytochrome P450 epoxygenases as EDHF synthase(s).

21 January 2018

1 reference

The coronary endothelium-derived hyperpolarizing factor (EDHF) stimulates multiple signalling pathways and proliferation in vascular cells.

21 January 2018

1 reference

Endothelium-derived hyperpolarizing factor synthase (Cytochrome P450 2C9) is a functionally significant source of reactive oxygen species in coronary arteries.

21 January 2018

1 reference

Reduction of ischemia and reperfusion-induced myocardial damage by cytochrome P450 inhibitors

21 January 2018

1 reference

Changes in coronary endothelial function predict progression of allograft vasculopathy after heart transplantation

21 January 2018

1 reference

Cytochrome p450 enzymes and cardiovascular disease

21 January 2018

1 reference

Cytochrome p450 2C inhibition reduces post-ischemic vascular dysfunction

21 January 2018

1 reference

Epoxygenase metabolites contribute to nitric oxide-independent afferent arteriolar vasodilation in response to bradykinin

21 January 2018

1 reference

Nitric oxide: an endogenous modulator of leukocyte adhesion

21 January 2018

1 reference

Epoxyeicosatrienoic acids activate K+ channels in coronary smooth muscle through a guanine nucleotide binding protein.

21 January 2018

1 reference

Epoxygenase-driven angiogenesis in human lung microvascular endothelial cells

21 January 2018

1 reference

The L-arginine-nitric oxide pathway

21 January 2018

1 reference

Role of desethylamiodarone in the anticoagulant effect of concurrent amiodarone and warfarin therapy

21 January 2018

1 reference

Cytochrome P450 and the individuality of species

21 January 2018

1 reference

Inhibition of cytochrome P450omega-hydroxylase: a novel endogenous cardioprotective pathway

21 January 2018

1 reference

Atherosclerosis is an inflammatory disease

21 January 2018

1 reference

Enhanced postischemic functional recovery in CYP2J2 transgenic hearts involves mitochondrial ATP-sensitive K+ channels and p42/p44 MAPK pathway

21 January 2018

1 reference

Impaired renal function is associated with markers of endothelial dysfunction and increased inflammatory activity

21 January 2018

1 reference

The risk of overanticoagulation in patients with cytochrome P450 CYP2C9*2 or CYP2C9*3 alleles on acenocoumarol or phenprocoumon

21 January 2018

1 reference

Allelic variants of cytochromes P450 2C modify the risk for acute myocardial infarction

21 January 2018

1 reference

Relationship between CYP2C9 and 2C19 genotypes and tolbutamide methyl hydroxylation and S-mephenytoin 4'-hydroxylation activities in livers of Japanese and Caucasian populations

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1139/Y05-139

1 reference

14 August 2017

1 reference